How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Vasilios Tsimihodimos, Matilda Florentin and Moses S. Elisaf
Pages 3773-3787 (15)
Type 2 diabetes mellitus (T2DM) is a serious health problem with epidemic proportions and associated with high cardiovascular
morbidity and mortality. Thus, the prevention or at least delaying the onset of T2DM is imperative. Subjects with impaired glucose
metabolism (prediabetes) are highly likely to develop overt T2DM. Treatment of accompanied cardiovascular risk factors, such as hypertension
and dyslipidemia, in these patients is frequently complicated as it can impair the already altered glucose homeostasis. This review
discusses the pathophysiology of lipid disorders and hypertension in prediabetes along with the effects of lipid modifying and antihypertensive
drugs in glucose/insulin metabolism. A critical overview and suggestions of different treatment options for prediabetic patients
with dyslipidemia and/or hypertension are also presented.
Aldosterone, angiotensin, dyslipidemia, fibrates, hypertension, new-onset diabetes, prediabetes, statins.
Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.